Taris

Therapeutic Areas

TARIS is focusing its development efforts in disease areas with high unmet need in which current therapies or systemic treatments have failed. Bladder diseases, which are difficult to treat with systemic therapies, affect 50 million people in the US alone. These disease include:

Therapeutic Areas Patient Distribution

*From internal market research, American Urology Association, NCI, OBGYN literature, IMS Health.

The first area of focus for TARIS is Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS)

Bladder diseases are characterized by high unmet medical need due to a lack of effective therapeutic options. Although some oral therapies are available, systemic treatment often has little or no efficacy. Other therapies have limited effectiveness due to treatment-limiting side effects or requiring frequent, repeated applications.